| Title | Date |
|---|---|
|
[ProteomeTech] 2020 MEDICAL JAPAN
|
2020.03.20 |
|
[ProteomeTech] 2020 MEDLAB
|
2020.03.05 |
|
[PROTEOMETECH] 2019 CMEF (SHANGHAI).
|
2019.05.22 |
|
[PROTEOMETECH] 2019 Medlab Asia Pacific(Singapore)
|
2019.04.01 |
In vitro Diagnostic Kits
Multiple screening allergy diagnostic kit that detects up to over 60 allergens in a single test
Q-Station Elite Video
Q-Scan plus Video
Q-Smart Video
Q-Processor Video
IgG quantitative POCT for measuring total human IgG concentration in whole blood or serum
Proteomics Technology
Why Proteomics?
A biomarker, or biological marker, is in general a substance used as an indicator of a biological state.
It is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarker discovery has been accelerated by proteomics, which study to entire protein expression at any given time in cell or tissue. If a certain protein is the functional molecule in cells, measurement of the differential expression of proteins could indicate disease-specific changes in tissues or organs.
Mass spectrometry (MS) is an analytical technique that measures the molecular weight of molecules based upon the motion of a charged particle in an electric or magnetic field. It is used for determining masses of particles, for determining the elemental composition of a sample or molecule, and for elucidating the chemical structures of molecules, such as peptides and other chemical compounds. This technique is performed by a mass spectrometer. The MS principle consists of ionizing chemical compounds to generate charged molecules or molecule fragments and measuring their mass-to-charge ratios (m/z).
The Reliable Business Partner!
Innovative Technology
& Novel Diagnostics
Request A Quote
Q&A
Quality Control PGM
Careers